Quantcast

Latest CD135 Stories

2013-08-19 23:18:19

“OpportunityAnalyzer: Acute Myeloid Leukemia (AML) - Opportunity Analysis and Forecasts to 2017” is the new market research report added to ReportsnReports.com store. Acute Myeloid Leukemia (AML) therapeutics market to $430.7m in 2017, at a CAGR of 23.3%. Dallas, Texas (PRWEB) August 19, 2013 Acute myeloid (myelogenous, myelocytic) leukemia is a rapidly progressing blood cancer with a poor overall prognosis. AML is relatively rare, and predominantly affects older adults. AML is a...

2013-08-15 23:20:42

"OpportunityAnalyzer: Acute Myeloid Leukemia (AML) - Opportunity Analysis and Forecasts to 2017" – this new report says the main driver of growth in the global Acute Myeloid Leukemia market will be the uptake of premium-priced pipeline agents. Dallas, TX (PRWEB) August 15, 2013 Key R&D trends in the Acute Myeloid Leukemia market include developing therapies for the patients with greatest unmet need, particularly the elderly, developing combination therapies, and...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related